Oric Pharmaceuticals, Inc.·4

Jun 17, 7:49 PM ET

Svennilson Peter 4

4 · Oric Pharmaceuticals, Inc. · Filed Jun 17, 2021

Insider Transaction Report

Form 4
Period: 2021-06-16
Svennilson Peter
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-16+16,62516,625 total
    Exercise: $19.03Exp: 2031-06-15Common Stock (16,625 underlying)
Footnotes (1)
  • [F1]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 16, 2022 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_994110

    POA DOCUMENT